JPWO2022072244A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022072244A5 JPWO2022072244A5 JP2023520059A JP2023520059A JPWO2022072244A5 JP WO2022072244 A5 JPWO2022072244 A5 JP WO2022072244A5 JP 2023520059 A JP2023520059 A JP 2023520059A JP 2023520059 A JP2023520059 A JP 2023520059A JP WO2022072244 A5 JPWO2022072244 A5 JP WO2022072244A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- shtg
- fpl
- fcs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063087095P | 2020-10-02 | 2020-10-02 | |
| US63/087,095 | 2020-10-02 | ||
| PCT/US2021/052001 WO2022072244A1 (en) | 2020-10-02 | 2021-09-24 | Methods for reducing apociii expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023543898A JP2023543898A (ja) | 2023-10-18 |
| JP2023543898A5 JP2023543898A5 (https=) | 2024-10-02 |
| JPWO2022072244A5 true JPWO2022072244A5 (https=) | 2024-10-02 |
Family
ID=80950871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520059A Pending JP2023543898A (ja) | 2020-10-02 | 2021-09-24 | Ａｐｏｃｉｉｉ発現を減少させるための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240033280A1 (https=) |
| EP (1) | EP4221720A4 (https=) |
| JP (1) | JP2023543898A (https=) |
| KR (1) | KR20230079394A (https=) |
| CN (1) | CN116348125A (https=) |
| AU (1) | AU2021353849A1 (https=) |
| BR (1) | BR112023004012A2 (https=) |
| IL (1) | IL300882A (https=) |
| MX (1) | MX2023003855A (https=) |
| WO (1) | WO2022072244A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL277889B2 (en) | 2018-04-12 | 2025-01-01 | Wave Life Sciences Ltd | Oligonucleotide preparations and methods of using them |
| EP3790596A4 (en) | 2018-05-11 | 2022-04-06 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE |
| AU2023372971A1 (en) * | 2022-11-02 | 2025-05-15 | Ionis Pharmaceuticals, Inc. | Methods for modulating complement factor b expression |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7598227B2 (en) * | 2003-04-16 | 2009-10-06 | Isis Pharmaceuticals Inc. | Modulation of apolipoprotein C-III expression |
| AU2014216137B2 (en) * | 2013-02-14 | 2018-05-10 | Ionis Pharmaceuticals, Inc. | Modulation of Apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations |
| JP2018511555A (ja) * | 2015-02-27 | 2018-04-26 | アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | リポジストロフィー集団におけるアポリポタンパク質Ｃ−ＩＩＩ（ＡｐｏＣＩＩＩ）発現の調節 |
| US20190046555A1 (en) * | 2015-11-06 | 2019-02-14 | Ionis Pharmaceuticals, Inc. | Conjugated antisense compounds for use in therapy |
-
2021
- 2021-09-24 IL IL300882A patent/IL300882A/en unknown
- 2021-09-24 BR BR112023004012A patent/BR112023004012A2/pt unknown
- 2021-09-24 US US18/247,567 patent/US20240033280A1/en active Pending
- 2021-09-24 MX MX2023003855A patent/MX2023003855A/es unknown
- 2021-09-24 EP EP21876250.8A patent/EP4221720A4/en active Pending
- 2021-09-24 CN CN202180066569.6A patent/CN116348125A/zh active Pending
- 2021-09-24 KR KR1020237013301A patent/KR20230079394A/ko active Pending
- 2021-09-24 JP JP2023520059A patent/JP2023543898A/ja active Pending
- 2021-09-24 AU AU2021353849A patent/AU2021353849A1/en active Pending
- 2021-09-24 WO PCT/US2021/052001 patent/WO2022072244A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2110993C1 (ru) | Синергетическая фармацевтическая комбинация, фармацевтическая композиция и способ лечения или профилактики вич-инфекций | |
| JP2026041749A5 (https=) | ||
| US6608035B1 (en) | Method of down-regulating gene expression | |
| US6645943B1 (en) | Method of down-regulating gene expression | |
| ES2266402T3 (es) | L-nucleosidos para el tratamiento del virus de la hepatitis b y el virus de epstein-barr. | |
| CA2203652C (en) | A method of down-regulating gene expression | |
| PT707481E (pt) | Analogos de l-2',3'-didesoxinucleosido como agentes anti-hepatite b (hbv) e anti-hiv | |
| JP2017532982A (ja) | Ｓｍａｄ７アンチセンスオリゴヌクレオチドの同位体置換体 | |
| US20130261070A1 (en) | Anti-epileptogenic agents | |
| PT89050B (pt) | Meios e metodo para intensificar a hibridacao de acidos nucleicos | |
| KR100290132B1 (ko) | 전신 염증 및 염증성 간염 치료용 피리미딘 누클레오티드 전구체 | |
| WO2001054728A1 (fr) | NOUVEAUX REMEDES ET UTILISATION D'UN AGONISTE β3 | |
| US5869461A (en) | Reducing toxicity of L-nucleosides with D-nucleosides | |
| JP2024037841A5 (https=) | ||
| JPH11513992A (ja) | シチジンデアミナーゼまたはデオキシシチジンデアミナーゼの過剰発現を伴う疾患を治療するための薬剤および方法 | |
| CN102058614A (zh) | 腺苷受体激动剂在治疗中的用途 | |
| KR940010441B1 (ko) | B형감염의 항비루스제 | |
| US6432924B1 (en) | Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase | |
| JPWO2022072244A5 (https=) | ||
| JP2002080490A (ja) | 新規ヌクレオシド | |
| JP2005162757A (ja) | 全身性炎症と炎症性肝炎の治療のためのピリミジンヌクレオチド前駆体 | |
| CN119632973A (zh) | 漆黄素制备治疗心脏有关疾病的药物中的应用 | |
| CN120284994A (zh) | 5-溴胞苷在制备治疗高尿酸血症药物或保健品中的应用 | |
| WO2022250072A1 (ja) | 心疾患治療薬 | |
| EP1007098B1 (en) | Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |